Dr. Chih-Yi Liao
Claim this profileUniversity of Chicago Comprehensive Cancer Center
Studies Pancreatic Cancer
Studies Pancreatic Neuroendocrine Tumors
16 reported clinical trials
32 drugs studied
Area of expertise
1Pancreatic Cancer
Stage IV
Stage III
Ki-67 positive
2Pancreatic Neuroendocrine Tumors
Stage IV
Stage III
Ki-67 positive
Affiliated Hospitals
Clinical Trials Chih-Yi Liao is currently running
Atezolizumab + Multi-Kinase Inhibitor
for Liver Cancer
This phase II trial tests whether atezolizumab in combination with a multi-kinase inhibitor (cabozantinib or lenvatinib) compared to multi-kinase inhibitor alone in treating patients with liver cancer that cannot be removed by surgery (unresectable), has spread to has spread to nearby tissue or lymph nodes (locally advanced), or has spread to other places in the body (metastatic), for which the patient has received treatment in the past (previously treated). Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Cabozantinib and lenvatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving atezolizumab with cabozantinib or lenvatinib may kill more tumor cells in patients with liver cancer.
Recruiting1 award Phase 23 criteria
Targeted Alpha-Particle Therapy
for Neuroendocrine Tumors
This study is Phase I/IIa First-in-Human Study of \[212Pb\]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors
Recruiting1 award Phase 1 & 213 criteria
More about Chih-Yi Liao
Clinical Trial Related3 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Chih-Yi Liao has experience with
- Temozolomide
- Capecitabine
- Trastuzumab
- Tucatinib
- Fluorouracil
- Lutetium Lu 177 Dotatate
Breakdown of trials Chih-Yi Liao has run
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Cancer
Bile Duct Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Chih-Yi Liao specialize in?
Chih-Yi Liao focuses on Pancreatic Cancer and Pancreatic Neuroendocrine Tumors. In particular, much of their work with Pancreatic Cancer has involved Stage IV patients, or patients who are Stage III.
Is Chih-Yi Liao currently recruiting for clinical trials?
Yes, Chih-Yi Liao is currently recruiting for 6 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Chih-Yi Liao has studied deeply?
Yes, Chih-Yi Liao has studied treatments such as Temozolomide, Capecitabine, Trastuzumab.
What is the best way to schedule an appointment with Chih-Yi Liao?
Apply for one of the trials that Chih-Yi Liao is conducting.
What is the office address of Chih-Yi Liao?
The office of Chih-Yi Liao is located at: University of Chicago Comprehensive Cancer Center, Chicago, Illinois 60637 United States. This is the address for their practice at the University of Chicago Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.